AI Scribe Regulation: What Clinicians and Developers Need to Know

Is your AI scribe secretly a regulated medical device? The Medicines and Healthcare products Regulatory Agency (MHRA) has just released landmark guidance defining exactly when ambient voice technology crosses the regulatory line. This breakdown explores the practical boundaries between administrative tools and regulated clinical software to keep your practice compliant. This guidance it produced by the UK but similar principles are likely to be relevant elsewhere.

Reference: https://www.gov.uk/government/publications/ambient-voice-technology-enabled-products/ambient-voice-technology-enabled-products

Understanding where the regulatory boundary lies is essential as ambient voice technology rapidly spreads across NHS clinics and GP surgeries. The MHRA has clarified that an AI scribe's classification depends on its intended purpose and clinical features, rather than its underlying large language model. While administrative tasks like literal transcription, summarisation, and explicit code matching remain unregulated, any feature that generates clinical insights, operates autonomously, or guides diagnosis elevates the tool to a medical device status. Clinicians and healthcare managers must understand this distinction to manage liability, prevent feature creep, and implement safe workflow solutions today.

Key Takeaways

• Identify the exact boundaries that separate unregulated administrative scribes from regulated medical devices under the new MHRA guidelines.

• Master the legal and clinical risks of "feature creep" where silent software updates can instantly change your software's regulatory status.

• Deploy safe, compliant ambient voice features immediately in your GP surgery or NHS Trust without waiting for device certification.

00:00 - Is Your AI Scribe a Medical Device? (MHRA Guidance Overview)

00:29 - AI Scribe Functions That Are NOT Medical Devices (Administrative Use)

01:58 - What Triggers Medical Device Classification? (Clinical Decision Support)

02:37 - How Marketing Claims and Disclaimers Affect Regulatory Status

03:07 - The Compliance Risks of Generative AI and "Over-the-Air" Updates